Tetraphase Pharmaceuticals Inc (TTPH) Return on Assets ROA from the first quarter of 2020 to first quarter of 2019 and for the year 2020, Average High and Low, Fundamental Ratios from Mar 31 2020 to Mar 31 2019 - CSIMarket
CSIMarket
 


Tetraphase Pharmaceuticals Inc  (NASDAQ: TTPH)


Tetraphase Pharmaceuticals Inc's ROA from the first quarter of 2020 to the first quarter of 2019 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Tetraphase Pharmaceuticals Inc's ROA in the first quarter of 2020?
Tetraphase Pharmaceuticals Inc recorded a cumulative net loss of $-63 million during 12 months ending in the first quarter of 2020, resulting in a negative return on assets (ROA) of -133.51%.

However, within the Healthcare sector 791 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2020 quarter, so far to 4671, from total ROA ranking in the fourth quarter of 2019 at 5124.

What is ROA?



Return On Assets (Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
Y / Y Total Assets Change -68.23 % -74.34 % -66.73 % -30.59 % -15.44 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -63 -70 -80 -83 -70
Return On Assets (TTM) -133.51 % -106.77 % -90.63 % -77.93 % -60.2 %
TTPH's Total Ranking # 4671 # 5124 # 4557 # 4525 # 4471
Total Assets (TTM) in million 35 32 37 85 109
Seq. Total Assets Change 10.16 % -14.92 % -56.13 % -22.73 % -11.02 %
Seq. Net Income Change - - - - -



Return On Assets Company Ranking
Within: No.
Industry # 397
Sector # 792
Overall # 4501

Return On Assets Statistics
High Average Low
-33.62 %
-61.17 %
-121.73 %
(Jun 30 2016)   (Mar 31 2020)





Financial Statements
Tetraphase Pharmaceuticals Inc's Assets $ 35 million TTPH's Balance sheet
Tetraphase Pharmaceuticals Inc's Income $ -12 million Quarterly TTPH's Income Statement
TTPH's Income by Division See TTPH's Income by Division



Annual Return On Assets (Dec 31 2019)
FY 2019
(Dec 31 2018)
FY 2018
(Dec 31 2017)
FY 2017
(Dec 31 2016)
FY 2016
(Dec 31 2015)
FY 2015
Y / Y Total Assets Change -74.34 % -17.51 % -1.76 % -29.41 % 68.95 %
Total Assets in million 32 123 149 152 215
Y / Y Net Income Change - - - - -
Net Income in million -70 -72 -115 -77 -83
Annual Return On Assets -222.15 % -58.69 % -76.99 % -51.07 % -38.71 %




More Return On Assets Ratios
TTPH's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
TTPH's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for TTPH's Competitors
Subscribers only: Roa for Tetraphase Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Assets for TTPH's Customers

You may also want to know
TTPH's Roi TTPH's Inventory Turnover Ratio TTPH's Growth Rates TTPH's Dividend Comparisons
TTPH's Profitability Ratios TTPH's Asset Turnover Ratio TTPH's Dividend Growth
TTPH's Roe TTPH's Valuation Ratios TTPH's Financial Strength Ratios TTPH's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2020, within Healthcare Sector ROA


Date modified: 2026-08-29T17:23:57+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.